Patient Portal

Matthew A. Ciorba, MD

Associate Professor, Medicine
Division of Gastroenterology
Director, Inflammatory Bowel Disease Program

Specialty Areas

Gastroenterology
Gastrointestinal Disease
Inflammatory Bowel Disease

Board Certifications

Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Gastroenterology, inflammatory bowel disease, Crohn's disease

  • Maps & Directions
  • Education
  • Publication & Research
  • In the News
  • Financial Disclosures
  • Videos

Maps & Directions

Maps & Directions

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 8
Office Phone: 314-747-2066

Education

Education

Fellowship: Gastroenterology, Washington University School of Medicine, St. Louis, Missouri 2007
Residency: Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 2003
M.D.: University of Iowa College of Medicine, Iowa City, Iowa 2001
B.S.: Exercise Science, University of Iowa College of Liberal Arts, Iowa City, Iowa 1996

Publication & Research

Publication & Research

Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections After Arthroplasty.
Gregory MH, McKinnon A, Stwalley D, Hippensteel KJ, Loftus EV Jr, Ciorba MA, Olsen MA, Deepak P
J Crohns Colitis. 2018 Sep 26; doi: 10.1093/ecco-jcc/jjy148.

PMID:
    30256926
    [PubMed - as supplied by publisher]
Related citations


<i>Lactobacillus rhamnosus</i> GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells.
Riehl TE, Alvarado D, Ee X, Zuckerman A, Foster L, Kapoor V, Thotala D, Ciorba MA, Stenson WF
Gut. 2018 Jun 22; pii: gutjnl-2018-316226. doi: 10.1136/gutjnl-2018-316226.

PMID:
    29934438
    [PubMed - as supplied by publisher]
Related citations


Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.
Sofia MA, Ciorba MA, Meckel K, Lim CK, Guillemin GJ, Weber CR, Bissonnette M, Pekow JR
Inflamm Bowel Dis. 2018 Jun 8; 24(7)1471-1480. doi: 10.1093/ibd/izy103.

PMID:
    29796641
    [PubMed - in process]
Related citations


Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.
VanDussen KL, Stojmirović A, Li K, Liu TC, Kimes PK, Muegge BD, Simpson KF, Ciorba MA, Perrigoue JG, Friedman JR, Towne JE, Head RD, Stappenbeck TS
Gastroenterology. 2018 Sep; 155(3)815-828. doi: 10.1053/j.gastro.2018.05.028.

PMID:
    29782846
    [PubMed - indexed for MEDLINE]
Related citations


Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.
Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM
J Clin Invest. 2018 Aug 1; 128(8)3298-3311. doi: 10.1172/JCI97659.

PMID:
    29771685
    [PubMed - in process]
Related citations


Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis.
Wardill HR, Van Sebille YZA, Ciorba MA, Bowen JM
Curr Opin Support Palliat Care. 2018 Jun; 12(2)187-197. doi: 10.1097/SPC.0000000000000338.

PMID:
    29547491
    [PubMed - in process]
Related citations


A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli.
Brown JW, Badahdah A, Iticovici M, Vickers TJ, Alvarado DM, Helmerhorst EJ, Oppenheim FG, Mills JC, Ciorba MA, Fleckenstein JM, Bullitt E
J Infect Dis. 2018 Apr 11; 217(9)1435-1441. doi: 10.1093/infdis/jiy032.

PMID:
    29528423
    [PubMed - in process]
Related citations


Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.
Afzali A, Ciorba MA, Schwartz DA, Sharaf M, Fourment C, Ritter T, Wolf DC, Shafran I, Randall CW, Kane SV
Inflamm Bowel Dis. 2017 Dec 19; 24(1)2-4. doi: 10.1093/ibd/izx015.

PMID:
    29272481
    [PubMed - in process]
Related citations


De-novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case Series.
Braga Neto MB, Gregory M, Ramos GP, Loftus EV Jr, Ciorba MA, Bruining DH, Bazerbachi F, Abu Dayyeh BK, Kushnir VM, Shah M, Collazo-Clavell ML, Raffals LE, Deepak P
J Crohns Colitis. 2018 Mar 28; 12(4)452-457. doi: 10.1093/ecco-jcc/jjx177.

PMID:
    29272375
    [PubMed - indexed for MEDLINE]
Related citations


Progress in PD-1-based Immunotherapy: New Mechanistic Insight May Provide Expanded Hope for Application to Colon and Gastrointestinal Cancers.
Park H, Chen B, Ciorba MA
Gastroenterology. 2017 Oct; 153(4)1162-1163. doi: 10.1053/j.gastro.2017.08.050.

PMID:
    28867277
    [PubMed - in process]
Related citations


Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions.
Sheikh A, Rashu R, Begum YA, Kuhlman FM, Ciorba MA, Hultgren SJ, Qadri F, Fleckenstein JM
PLoS Negl Trop Dis. 2017 May; 11(5)e0005586. doi: 10.1371/journal.pntd.0005586.

PMID:
    28531220
    [PubMed - indexed for MEDLINE]
Related citations


Pneumococcal Disease in Inflammatory Bowel Disease: Justification to Vaccinate at Diagnosis.
Cushing KC, Kanuri N, Ciorba MA
Gastroenterology. 2016 Aug; 151(2)365-6. doi: 10.1053/j.gastro.2016.06.027.

PMID:
    27375193
    [PubMed]
Related citations


Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.
Christophi GP, Rengarajan A, Ciorba MA
Clin Exp Gastroenterol. 2016; 9125-30. doi: 10.2147/CEG.S80237.

PMID:
    27274301
    [PubMed]
Related citations


Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
Patel A, Hasak S, Cassell B, Ciorba MA, Vivio EE, Kumar M, Gyawali CP, Sayuk GS
Aliment Pharmacol Ther. 2016 Aug; 44(3)246-58. doi: 10.1111/apt.13677.

PMID:
    27240555
    [PubMed - indexed for MEDLINE]
Related citations


Probiotic Gut Bacteria Enhance Cancer Immunotherapy in a Mouse Model of Melanoma.
Dey N, Ciorba MA
Gastroenterology. 2016 Jul; 151(1)206-7. doi: 10.1053/j.gastro.2016.05.015.

PMID:
    27238844
    [PubMed]
Related citations


Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera.
Kuhlmann FM, Santhanam S, Kumar P, Luo Q, Ciorba MA, Fleckenstein JM
Am J Trop Med Hyg. 2016 Aug 3; 95(2)440-3. doi: 10.4269/ajtmh.16-0161.

PMID:
    27162272
    [PubMed - indexed for MEDLINE]
Related citations


Advances in understanding and improving gastrointestinal symptoms during supportive and palliative care: a decade of progress.
Ciorba MA
Curr Opin Support Palliat Care. 2016 Jun; 10(2)149-51. doi: 10.1097/SPC.0000000000000215.

PMID:
    27054289
    [PubMed - indexed for MEDLINE]
Related citations


Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice.
Vivio EE, Kanuri N, Gilbertsen JJ, Monroe K, Dey N, Chen CH, Gutierrez AM, Ciorba MA
J Crohns Colitis. 2016 Apr; 10(4)402-9. doi: 10.1093/ecco-jcc/jjv226.

PMID:
    26681763
    [PubMed - indexed for MEDLINE]
Related citations


Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation.
Cushing K, Alvarado DM, Ciorba MA
Clin Transl Gastroenterol. 2015 Aug 27; 6e108. doi: 10.1038/ctg.2015.34.

PMID:
    26312412
    [PubMed]
Related citations


Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.
Santhanam S, Alvarado DM, Ciorba MA
Transl Res. 2016 Jan; 167(1)67-79. doi: 10.1016/j.trsl.2015.07.003.

PMID:
    26297050
    [PubMed - indexed for MEDLINE]
Related citations

In the News

In the News

Matthew Ciorba, MD

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2017:

Company Name: Abbott

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $40,000 - $59,999

Reporting Date: May 01, 2018


Company Name: Takeda

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $60,000 - $79,999

Reporting Date: May 01, 2018

Videos

Videos